DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ipratropium (Ipratropium Bromide Monohydrate Nasal) - Current Clinical Trials

 
 



Ipratropium Related Clinical Trials

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes [Completed]

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients [Completed]

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT� Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation [Completed]

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Completed]

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium [Completed]

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment [Completed]

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Completed]

Budesonide Inhalation Suspension for Acute Asthma in Children [Completed]

Ipratropium Bromide in Peri-Operative COPD [Active, not recruiting]

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. [Completed]

Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease [Completed]

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease [Completed]

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness [Completed]

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children [Terminated]

PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease [Terminated]

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101 in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study [Completed]

Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease [Completed]

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease [Completed]

Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease [Completed]

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease [Completed]

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease [Completed]

Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease [Completed]

Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease [Completed]

Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease [Completed]

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease [Completed]

Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy [Completed]

Optimising the Propranolol Block Model [Completed]

A Crossover Study in the Treatment of Patients With COPD [Completed]

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD [Completed]

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children [Not yet recruiting]

Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction [Completed]

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Completed]

Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population [Completed]

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM) [Completed]

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017 [Recruiting]

Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State [Recruiting]

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. [Active, not recruiting]

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room [Completed]

Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation [Completed]

HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia [Completed]

GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients [Recruiting]

Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment [Completed]

Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients [Completed]

Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma [Completed]

Nebulized Magnesium Sulfate in Pediatric Asthma [Terminated]

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD [Completed]

Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent� Inhalation Aerosol in COPD Patients. [Completed]

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Ventilator Adapters for Combivent Respimat [Completed]

Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies [Completed]

Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Prevention of Lung Edema After Thoracic Surgery [Completed]

Lung Health Study (LHS) I and III [Completed]

Effect of Nebulized Bronchodilators on Heart Rate [Completed]

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. [Completed]

Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects [Completed]

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD [Terminated]

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Terminated]

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma [Terminated]

A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) [Terminated]

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) [Completed]

A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients [Terminated]

A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD [Not yet recruiting]

Berodual� Respimat� vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease [Terminated]

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Radioaerosol Pulmonary Deposition During Asthma Exacerbation Through Noninvasive Ventilation [Completed]

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD [Completed]

COPD AND ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION [Completed]

Asthma and Quantifying Delivery Of Radio Labeled Aerosol [Completed]

Magnesium Nebulization Utilization in Management of Pediatric Asthma [Recruiting]

Plethysmography Opto-electronic and Asthma [Completed]

Radioaerossol Pulmonary Deposition Using Mesh in Normal Subjects [Completed]

Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Completed]

Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) [Completed]

WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction [Completed]

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD [Completed]

Hemodynamics and Extravascular Lung Water in Acute Lung Injury [Completed]

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma [Recruiting]

Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma Patients [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017